UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

Clinical pharmacology and therapeutics, 2015-07, Vol.98 (1), p.19-24

2015

Volltextzugriff (PDF)

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

The pharmacogenomics journal, 2011-08, Vol.11 (4), p.274-286

2011

Volltextzugriff (PDF)

Profiling Solute Carrier Transporters in the Human Blood-Brain Barrier

Clinical pharmacology and therapeutics, 2013-12, Vol.94 (6), p.636-639

2013

Volltextzugriff (PDF)

The Relevance of "Missing Heritability " in Pharmacogenomics

Clinical pharmacology and therapeutics, 2012-10, Vol.92 (4), p.428-430

Sadee, W

2012

Volltextzugriff (PDF)

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World Implementation

Clinical pharmacology and therapeutics, 2013-08, Vol.94 (2), p.207-210

2013

Volltextzugriff (PDF)

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems

Clinical pharmacology and therapeutics, 2017-09, Vol.102 (3), p.502-510

2017

Volltextzugriff (PDF)

Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons

Molecular psychiatry, 2007-05, Vol.12 (5), p.491-501

2007

Volltextzugriff (PDF)

Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines

The pharmacogenomics journal, 2017-03, Vol.17 (2), p.137-145

2017

Volltextzugriff (PDF)

Allelic expression of serotonin transporter (SERT) mRNA in human pons : lack of correlation with the polymorphism SERTLPR

Molecular psychiatry, 2006-07, Vol.11 (7), p.649-662

2006

Volltextzugriff (PDF)

Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction

Translational psychiatry, 2013-01, Vol.3 (1), p.e222-e222

2013

Volltextzugriff (PDF)

Pharmacogenomics of the RNA World: Structural RNA Polymorphisms in Drug Therapy

Clinical pharmacology and therapeutics, 2011-03, Vol.89 (3), p.355-365

2011

Volltextzugriff (PDF)

Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics

Pharmacology & therapeutics (Oxford), 2005-04, Vol.106 (1), p.19-38

2005

Volltextzugriff (PDF)

Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities

Life sciences (1973), 2005-02, Vol.76 (13), p.1427-1437

2005

Volltextzugriff (PDF)

Allelic mRNA expression imbalance in C-type lectins reveals a frequent regulatory SNP in the human surfactant protein A (SP-A) gene

Genes and immunity, 2013-03, Vol.14 (2), p.99-106

2013

Volltextzugriff (PDF)

The Relevance of Missing Heritability in Pharmacogenomics: INDIVIDUALIZATION

Clinical pharmacology and therapeutics, 2012, Vol.92 (4), p.428-430

SADEE, W

2012

Volltextzugriff (PDF)

Promoter Polymorphisms in ACE (Angiotensin I-Converting Enzyme) Associated With Clinical Outcomes in Hypertension

Clinical pharmacology and therapeutics, 2009-01, Vol.85 (1), p.36-44

2009

Volltextzugriff (PDF)

The Venus flytrap of periplasmic binding proteins: an ancient protein module present in multiple drug receptors

AAPS PharmSci, 1999-01, Vol.1 (2), p.E2-26

1999

Volltextzugriff (PDF)

Inverse agonists and neutral antagonists at µ opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence

Journal of neurochemistry, 2001-06, Vol.77 (6), p.1590-1600

2001

Volltextzugriff (PDF)

Pharmacogenetics/genomics and personalized medicine

Human molecular genetics, 2005-10, Vol.14 (suppl-2), p.R207-R214

2005

Volltextzugriff (PDF)

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma

Cancer research (Chicago, Ill.), 2005-05, Vol.65 (10), p.4320-4333

2005

Volltextzugriff (PDF)

Strategies and Methods for Research on Sex Differences in Brain and Behavior

Endocrinology (Philadelphia), 2005-04, Vol.146 (4), p.1650-1673

2005

Volltextzugriff (PDF)

5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter

Pharmaceutical research, 1998-08, Vol.15 (8), p.1154-1159

1998

Volltextzugriff (PDF)

Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance

Cancer research (Chicago, Ill.), 2005-08, Vol.65 (16), p.7446-7454

2005

Volltextzugriff (PDF)

Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G

The Journal of biological chemistry, 2005-09, Vol.280 (38), p.32618-32624

2005

Volltextzugriff (PDF)

Phosphorylation and Agonist‐Specific Intracellular Trafficking of an Epitope‐Tagged μ‐Opioid Receptor Expressed in HEK 293 Cells

Journal of neurochemistry, 1995-10, Vol.65 (4), p.1636-1645

1995

Volltextzugriff (PDF)

1 – 25 von 327

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(293)
Mit Volltextzugriff
(267)

Publikationsform

Sprache

Englisch
(315)
Japanisch
(40)
Deutsch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(189)
Life Sciences & Biomedicine
(179)
Humans
(154)
Animals
(129)
Biological And Medical Sciences
(103)
Pharmacology & Pharmacy
(98)
Medical Sciences
(64)
Pharmacology. Drug Treatments
(56)
Rats
(53)
Biochemistry & Molecular Biology
(46)
Male
(46)
Fundamental And Applied Biological Sciences. Psychology
(42)
Chemistry
(38)
Cell Line
(37)
Kinetics
(36)
Female
(33)
Mice
(33)
Physical Sciences
(33)
Chemistry, Multidisciplinary
(27)
Molecular And Cellular Biology
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

Profiling Solute Carrier Transporters in the Human Blood-Brain Barrier

The Relevance of "Missing Heritability " in Pharmacogenomics

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World Implementation

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems

Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons

Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines

Allelic expression of serotonin transporter (SERT) mRNA in human pons : lack of correlation with the polymorphism SERTLPR

Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction

Pharmacogenomics of the RNA World: Structural RNA Polymorphisms in Drug Therapy

Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics

Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities

Allelic mRNA expression imbalance in C-type lectins reveals a frequent regulatory SNP in the human surfactant protein A (SP-A) gene

The Relevance of Missing Heritability in Pharmacogenomics: INDIVIDUALIZATION

Promoter Polymorphisms in ACE (Angiotensin I-Converting Enzyme) Associated With Clinical Outcomes in Hypertension

The Venus flytrap of periplasmic binding proteins: an ancient protein module present in multiple drug receptors

Inverse agonists and neutral antagonists at µ opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence

Pharmacogenetics/genomics and personalized medicine

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma

Strategies and Methods for Research on Sex Differences in Brain and Behavior

5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter

Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance

Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G

Phosphorylation and Agonist‐Specific Intracellular Trafficking of an Epitope‐Tagged μ‐Opioid Receptor Expressed in HEK 293 Cells

Suchergebnisse filtern